ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,077Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 1006

$1.12M Total Retail Price of All Prescriptions

Rank: 31 out of 1006

892 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 892 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

3% of this provider’s 892 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 14,726 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 674 533 1 2
LISINOPRIL 644 543 2 3
HYDROCHLOROTHIAZIDE 612 535 3 11
FUROSEMIDE 605 526 4 6
SIMVASTATIN 594 479 5 1
METOPROLOL TARTRATE 579 550 6 7
AMLODIPINE BESYLATE 556 510 7 4
OMEPRAZOLE 473 383 8 9
ATORVASTATIN CALCIUM 457 397 9 5
ATENOLOL 386 351 10 13
METOPROLOL SUCCINATE 366 299 11 12
METFORMIN HCL 364 281 12 10
LOSARTAN POTASSIUM 307 295 13 22
ALENDRONATE SODIUM 221 205 14 29
POTASSIUM CHLORIDE 211 185 15 30
GABAPENTIN 210 179 16 20
WARFARIN SODIUM 208 204 17 8
TRAMADOL HCL 195 168 18 35
CRESTOR 190 163 19 18
DIOVAN 182 158 20 16
PRAVASTATIN SODIUM 169 162 21 15
ZOLPIDEM TARTRATE 165 161 22 14
CITALOPRAM HBR 149 131 23 24
SERTRALINE HCL 147 130 24 19
SPIRIVA 144 136 25 48
NEXIUM 143 89 26 28
TAMSULOSIN HCL 143 122 26 23
TRIAMTERENE-HCTZ 142 138 28 58
ADVAIR DISKUS 132 108 29 37
ALLOPURINOL 125 111 30 31
METFORMIN HCL ER 121 115 31 56
DONEPEZIL HCL 121 120 31 17
CYMBALTA 118 88 33 41
HYDRALAZINE HCL 116 105 34 100
NAMENDA 114 114 35 34
LOVASTATIN 113 95 36 44
PANTOPRAZOLE SODIUM 112 101 37 32
GLIPIZIDE 109 109 38 69
PROAIR HFA 109 87 38 64
QUINAPRIL HCL 107 107 40 86
GLYBURIDE 103 91 R 41 65
KLOR-CON M20 101 101 42 70
ESCITALOPRAM OXALATE 100 100 43 27
TRICOR 91 71 44 101
CLOPIDOGREL 87 79 45 46
SYMBICORT 86 86 46 147
CIPROFLOXACIN HCL 83 80 47 75
FLUOXETINE HCL 81 66 48 85
LIPITOR 77 66 49 47
ISOSORBIDE MONONITRATE ER 77 77 49 59
HYDROCODONE-ACETAMINOPHEN 73 65 S3 51 25
FLUTICASONE PROPIONATE 71 53 52 55
ONGLYZA 70 58 53 230
PREDNISONE 70 64 53 33
JANUVIA 70 65 53 49
LANTUS SOLOSTAR 70 57 53 93
INSULIN SYRINGE 65 55 57 122
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 62 58 38
OXYBUTYNIN CHLORIDE ER 63 12 59 92
AZITHROMYCIN 63 52 59 39
DIOVAN HCT 62 56 61 60
RAMIPRIL 61 61 62 79
CARVEDILOL 61 50 62 36
NIFEDIPINE ER 60 60 64 166
LANSOPRAZOLE 59 59 65 141
SINGULAIR 57 32 66 82
DOXAZOSIN MESYLATE 57 36 66 87
METHYLPREDNISOLONE 56 49 68 148
BYSTOLIC 55 55 69 84
SYNTHROID 54 50 70 42
OXYBUTYNIN CHLORIDE 54 48 70 197
FELODIPINE ER 53 53 72 276
CEPHALEXIN 52 50 73 142
LEVOFLOXACIN 52 43 73 96
PLAVIX 52 48 73 61
ZETIA 52 40 73 51
NITROFURANTOIN MONO-MACRO 50 38 77 180
FENTANYL 50 46 S2 77 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.